Latest News about ICPT
Recent news which mentions ICPT
3 Stocks Primed for a Short Squeeze
April 04, 2021
From Motley Fool
The Promises Behind Terns' Multi-Pronged Pipeline
March 26, 2021
From Motley Fool
60 Biggest Movers From Yesterday
March 26, 2021
From Benzinga
65 Biggest Movers From Yesterday
March 16, 2021
From Benzinga
42 Stocks Moving In Monday's Mid-Day Session
March 15, 2021
From Benzinga
From Motley Fool
Stocks That Hit 52-Week Lows On Friday
March 05, 2021
From Benzinga
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
March 05, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 04, 2021
From Benzinga
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Tuesday
March 02, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
From Benzinga
70 Biggest Movers From Yesterday
February 26, 2021
From Benzinga
Intercept Pharmaceuticals Inc (ICPT) Q4 2020 Earnings Call Transcript
February 25, 2021
Tickers
ICPT
From Motley Fool
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2021
February 23, 2021
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
From Benzinga
3 Turnaround Stocks With 75% to 84% Upside, According to Wall Street
January 23, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 15, 2021
January 15, 2021
From Benzinga
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
January 05, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Monday
January 04, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 30, 2020
From Benzinga
The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
December 30, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 29, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
December 29, 2020
From Benzinga
The 10 Worst Performing Stocks of 2020
December 29, 2020
From Motley Fool
Stocks That Hit 52-Week Lows On Monday
December 28, 2020
From Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Monday
December 21, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|
|
|
|